US Patent Issued to Woolsey Pharmaceuticals on June 17 for "Methods of using rho kinase inhibitors to treat alzheimer's disease" (Virginia, New York Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,761, issued on June 17, was assigned to Woolsey Pharmaceuticals Inc. (St. Petersburg, Fla.).

"Methods of using rho kinase inhibitors to treat alzheimer's disease" was invented by Thomas MacAllister (Arlington, Va.) and Sven Jacobson (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of treating patients with AD using a rho kinase inhibitor. A preferred rho kinase inhibitor used according to the invention is fasudil, which is typically administered orally in a total daily dose of 70-140 mg. A preferred dosing regimen involves administering the daily dose in three equal portions throughout the day. Preferred methods continu...